Considering that urothelial neoplasms are among these occasionally PAX8-positive tumors, PAX8 cannot reliably be used to distinguish urothelial carcinoma from renal cancer in kidney masses [2] or from ovarian or endometrial cancer in pelvic masses as previously suggested [52]. This evidence concerns the gene PAX8 and urothelial carcinoma.